Leiden Academic Centre for Drug Research
The Leiden Academic Centre for Drug Research (LACDR) is a centre of excellence for multidisciplinary research on drug discovery and development.
Despite major advances in medicine- research, many common diseases such as cancers, neurological or cardiovascular diseases, or auto-immune diseases, still lack effective treatment, or are still often found incurable.
That is why our work to develop new and more effective drugs is essential. At the LACDR we work at the leading edge of drug-design and fundamental research of new drugs, optimization of existing drugs, and personalised medicine.
Education in Biopharmaceutical Sciences
Our education ranges the Bachelor's and Master's programs in Bio-Pharmaceutical Sciences, Pharmacy and the LACDR PhD programme. We are committed to providing quality graduate experiences in a personalized environment of cutting edge research and internationally renowned supervisors.
Research
Our research is focused in four divisions and one research centre: Cell Systems and Drug Safety, BioTherapeutics, Medicinal Chemistry, Systems Pharmacology and Pharmacy, and the Metabolomics and Analytics Centre, which you can find below:
News
Events
-
Special Van der Waals Colloquium featuring Chris Ferrie
-
Dynamics of Neuromesodermal Progenitors in Axial Stem Cell Models
-
Advancing precision oncology: insights from C-terminal FGFR2/3 truncations and MYC-driven mTOR inhibitor resistance
-
LED3 Lecture: P5-labeling to Generate Electrophilic Probes and Highly Efficacious Antibody-Conjugates
Education
Study Association
